Health Catalyst, Inc.
HCATNasdaq
$2.25
↓ -1.3%Jul 17 close · end-of-day
Price
1Y↓ -40.6%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$163.3M
Enterprise Value
$207.9M
P/E
—
P/S
0.5
P/B
1.2
EV/EBITDA
—
PEG
—
FCF Yield
11.2%
Dividend Yield
—
Revenue (TTM)
$302.5M
Net Income (TTM)
-$265.3M
Free Cash Flow (TTM)
$18.3M
Gross Margin
—
Operating Margin
-81.7%
Net Margin
-87.7%
ROE
-192.0%
ROIC
-106.9%
Debt / Equity
1.1
Net Cash
-$44.5M
Return 1Y
-40.0%
Company profile
Management & directors
- Albert BenjaminPresident and COO
- Alger JasonChief Financial Officer
- Landry BenjaminGeneral Counsel
- Llewelyn LindaChief People Officer
- Burton Daniel D.Chief Executive Officer
- Freeman Kevin LeeChief Commercial Officer
- Lesueur DanielChief Operating Officer
- Ross David CoyChief Tech & Product Officer
Roles derived from SEC Form 4 filings.
Earnings
HCAT Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$70.8M↓ -10.9%
Diluted EPS-$1.53↑ +337.1%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $188.8M | $241.9M | $276.2M | $295.9M | $306.6M | $311.1M |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$96.1M | -$143.7M | -$140.0M | -$126.9M | -$69.8M | -$160.9M |
| Net income | -$115.0M | -$153.2M | -$137.4M | -$118.1M | -$69.5M | -$178.0M |
| Diluted EPS | -$2.91 | -$3.23 | -$2.63 | -$2.09 | -$1.15 | -$2.55 |
| Operating cash flow | -$26.1M | -$23.1M | -$35.3M | -$33.1M | $14.6M | $731,000.00 |
| Free cash flow | -$33.9M | -$33.6M | -$37.4M | -$34.3M | $12.9M | -$237,000.00 |
| Gross margin | — | — | — | — | — | — |
| Operating margin | -50.9% | -59.4% | -50.7% | -42.9% | -22.8% | -51.7% |
| Net margin | -60.9% | -63.3% | -49.7% | -39.9% | -22.7% | -57.2% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $75.9M | $76.4M | $79.6M | $79.4M | $80.7M | $76.3M | $74.7M | $70.8M |
| Gross profit | — | $36.3M | — | — | — | $40.1M | — | — |
| Operating income | -$15.8M | -$13.7M | -$17.5M | -$20.2M | -$37.1M | -$17.5M | -$86.1M | -$106.5M |
| Net income | -$13.5M | -$14.7M | -$20.7M | -$23.7M | -$41.0M | -$22.2M | -$91.0M | -$111.0M |
| Diluted EPS | -$0.23 | -$0.24 | -$0.33 | -$0.35 | -$0.59 | -$0.32 | -$1.29 | -$1.53 |
| Operating cash flow | $1.6M | $6.2M | -$3.5M | $280,000.00 | -$9.0M | -$464,000.00 | $9.9M | $18.5M |
| Free cash flow | $1.3M | $5.5M | -$3.9M | -$390,000.00 | -$9.2M | -$719,000.00 | $9.6M | $18.2M |
| Gross margin | — | 47.5% | — | — | — | 52.6% | — | — |
| Operating margin | -20.8% | -17.9% | -22.0% | -25.4% | -46.0% | -22.9% | -115.3% | -150.5% |
| Net margin | -17.8% | -19.3% | -26.0% | -29.9% | -50.8% | -29.1% | -121.9% | -156.9% |
Company news
Coming soonHeadlines for HCAT will appear here once the news feed is connected.
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-10 | Albert Benjamin· CEO | Tax withholding | 34,485 | $1.69 | $58,341.72 | filing |
| 2026-06-01 | Alger Jason· Chief Financial Officer | Tax withholding | 18,804 | $1.37 | $25,765.24 | filing |
| 2026-06-01 | Landry Benjamin· General Counsel | Tax withholding | 13,779 | $1.37 | $18,879.99 | filing |
| 2026-06-01 | Llewelyn Linda· Chief People Officer | Tax withholding | 8,519 | $1.37 | $11,672.73 | filing |
| 2026-06-01 | Albert Benjamin· CEO | Tax withholding | 336 | $1.37 | $460.39 | filing |
| 2026-06-01 | Larson-Green Julie | Award | 12,710 | $0.00 | $0.00 | filing |
| 2026-05-01 | Albert Benjamin· CEO | Tax withholding | 310 | $1.35 | $416.95 | filing |
| 2026-05-01 | Nelson Steven H | Award | 154,808 | $0.00 | $0.00 | filing |
| 2026-04-29 | Albert Benjamin· CEO | Award | 1,124 | $0.00 | $0.00 | filing |
| 2026-03-10 | Albert Benjamin· CEO | Tax withholding | 70,455 | $1.85 | $130,207.89 | filing |
| 2026-03-02 | Alger Jason· Chief Financial Officer | Tax withholding | 26,970 | $1.66 | $44,767.50 | filing |
| 2026-03-02 | Landry Benjamin· General Counsel | Tax withholding | 20,838 | $1.66 | $34,589.00 | filing |
| 2026-03-02 | Llewelyn Linda· Chief People Officer | Tax withholding | 13,836 | $1.66 | $22,966.38 | filing |
| 2026-03-02 | Albert Benjamin· CEO | Tax withholding | 4,966 | $1.66 | $8,243.06 | filing |
| 2026-03-01 | Larson-Green Julie | Award | 8,361 | $0.00 | $0.00 | filing |
| 2026-02-26 | Albert Benjamin· CEO | Tax withholding | 13,304 | $1.75 | $23,252.73 | filing |
| 2026-02-26 | Alger Jason· Chief Financial Officer | Tax withholding | 7,522 | $1.75 | $13,146.95 | filing |
| 2026-02-26 | Landry Benjamin· General Counsel | Tax withholding | 6,317 | $1.75 | $11,040.85 | filing |
| 2026-02-26 | Llewelyn Linda· Chief People Officer | Tax withholding | 4,471 | $1.75 | $7,814.41 | filing |
| 2026-02-25 | Landry Benjamin· General Counsel | Award | 16,473 | $0.00 | $0.00 | filing |
| 2026-02-25 | Alger Jason· Chief Financial Officer | Award | 507,500 | $0.00 | $0.00 | filing |
| 2026-02-25 | Alger Jason· Chief Financial Officer | Award | 22,222 | $0.00 | $0.00 | filing |
| 2026-02-25 | Albert Benjamin· CEO | Award | 930,000 | $0.00 | $0.00 | filing |
| 2026-02-25 | Albert Benjamin· CEO | Award | 38,833 | $0.00 | $0.00 | filing |
| 2026-02-25 | Llewelyn Linda· Chief People Officer | Award | 191,500 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.